Optimal Treatment for HR+/HER2- Breast Cancer Patients With Visceral Metastasis June 1, 2021Breast Cancer
Endocrine therapy benefits in premenopausal breast cancer differ by molecular riskMay 26, 2021Breast CancerMetastatic Breast Cancer
Evolving strategies in sequencing for HER2+ MBC therapyMay 25, 2021Metastatic Breast CancerBreast Cancer
New targeted treatments are major advances for HER2-positive breast cancerMay 21, 2021Breast CancerMetastatic Breast Cancer
GELATO trial: Chemoimmunotherapy may help in metastatic invasive lobular breast cancerMay 19, 2021Metastatic Breast CancerBreast Cancer
FDA panel votes against 2 cancer indications but backs 4 of 6April 30, 2021Breast CancerMetastatic Breast Cancer
